# FDA Inspection 1202632 - Antellis - April 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/antellis/5003c9ca-ebbc-4377-bb2d-added6a9e987
Source feed: FDA_Inspections

> FDA Inspection 1202632 for Antellis on April 13, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202632
- Company Name: Antellis
- Inspection Date: 2023-04-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/antellis/fc9b6759-e974-4456-84d3-389ed7cc94d2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c